Paper36937361
Enhancing intestinal barrier efficiency: A novel metabolic diseases therapy.
Zhang Y and 5 others. Front Nutr, 2023. Cited by 90 papers, by iCite.
Cite this record
ConductScience Library. Enhancing intestinal barrier efficiency: A novel metabolic diseases therapy. Papers, record 36937361. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36937361
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References261
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32016468 | Impact of a high‑fat diet on intestinal stem cells and epithelial barrier function in middle‑aged female mice. | Mol Med Rep | 2020 | https://conductscience.org/library/papers/32016468 | PubMed |
| 2 | 31266545 | Dietary fibre and cardiovascular health: a review of current evidence and policy. | Proc Nutr Soc | 2020 | https://conductscience.org/library/papers/31266545 | PubMed |
| 3 | 28504618 | Butyrate reduces high-fat diet-induced metabolic alterations, hepatic steatosis and pancreatic beta cell and intestinal barrier dysfunctions in prediabetic mice. | Exp Biol Med (Maywood) | 2017 | https://conductscience.org/library/papers/28504618 | PubMed |
| 4 | 34703027 | Adaptive immune cells shape obesity-associated type 2 diabetes mellitus and less prominent comorbidities. | Nat Rev Endocrinol | 2022 | https://conductscience.org/library/papers/34703027 | PubMed |
| 5 | 30366260 | Gut microbiome and type 2 diabetes: where we are and where to go? | J Nutr Biochem | 2019 | https://conductscience.org/library/papers/30366260 | PubMed |
| 6 | 27713957 | Antidiabetic (type 2) effects of Lactobacillus G15 and Q14 in rats through regulation of intestinal permeability and microbiota. | Food Funct | 2016 | https://conductscience.org/library/papers/27713957 | PubMed |
| 7 | 34507723 | Vitamin A supplementation ameliorates ulcerative colitis in gut microbiota-dependent manner. | Food Res Int | 2021 | https://conductscience.org/library/papers/34507723 | PubMed |
| 8 | 22344613 | Metabolic effects of aerobic training and resistance training in type 2 diabetic subjects: a randomized controlled trial (the RAED2 study). | Diabetes Care | 2012 | https://conductscience.org/library/papers/22344613 | PubMed |
| 9 | 29984492 | Increased jejunal permeability in human obesity is revealed by a lipid challenge and is linked to inflammation and type 2 diabetes. | J Pathol | 2018 | https://conductscience.org/library/papers/29984492 | PubMed |
| 10 | 33221482 | Abnormal food timing and predisposition to weight gain: Role of barrier dysfunction and microbiota. | Transl Res | 2021 | https://conductscience.org/library/papers/33221482 | PubMed |
| 11 | 25561785 | Role of interleukin-22 in inflammatory bowel disease. | World J Gastroenterol | 2014 | https://conductscience.org/library/papers/25561785 | PubMed |
| 12 | 32986965 | Intestinal barrier dysfunction as a therapeutic target for cardiovascular disease. | Am J Physiol Heart Circ Physiol | 2020 | https://conductscience.org/library/papers/32986965 | PubMed |
| 13 | 26102296 | Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota. | Nat Commun | 2015 | https://conductscience.org/library/papers/26102296 | PubMed |
| 14 | 31206525 | Lubiprostone as a potential therapeutic agent to improve intestinal permeability and prevent the development of atherosclerosis in apolipoprotein E-deficient mice. | PLoS One | 2019 | https://conductscience.org/library/papers/31206525 | PubMed |
| 15 | 28654658 | Butyrate modifies intestinal barrier function in IPEC-J2 cells through a selective upregulation of tight junction proteins and activation of the Akt signaling pathway. | PLoS One | 2017 | https://conductscience.org/library/papers/28654658 | PubMed |
| 16 | 18437274 | Influence of high and low protein intakes on age-related bone loss in rats submitted to adequate or restricted energy conditions. | Calcif Tissue Int | 2008 | https://conductscience.org/library/papers/18437274 | PubMed |
| 17 | 25865369 | Crosstalk between Microbiota-Derived Short-Chain Fatty Acids and Intestinal Epithelial HIF Augments Tissue Barrier Function. | Cell Host Microbe | 2015 | https://conductscience.org/library/papers/25865369 | PubMed |
| 18 | 33162192 | Effects of soluble fiber supplementation on glycemic control in adults with type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials. | Clin Nutr | 2021 | https://conductscience.org/library/papers/33162192 | PubMed |
| 19 | 34058177 | Metformin impairs bile acid homeostasis in ethinylestradiol-induced cholestasis in mice. | Chem Biol Interact | 2021 | https://conductscience.org/library/papers/34058177 | PubMed |
| 20 | 32747812 | Bariatric surgery reveals a gut-restricted TGR5 agonist with anti-diabetic effects. | Nat Chem Biol | 2021 | https://conductscience.org/library/papers/32747812 | PubMed |
Cited by70
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 90 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42940217 | Probiotic-Postbiotic Synergy and Microbial Co-Culture Strategies for Hyperuricemia: Gut Microbiota and Functional Food Perspectives. | Foods | 2026 | https://conductscience.org/library/papers/42940217 | PubMed |
| 42935632 | Gut Microbiota as a Mechanistic Nexus between Type 2 Diabetes and Alzheimer's Disease: Insulin Resistance, Neuroinflammation, and Functional Food Strategies. | Prev Nutr Food Sci | 2026 | https://conductscience.org/library/papers/42935632 | PubMed |
| 42862482 | Toxic Metals and Metalloids Exposure and the Gut-Cardiometabolic Axis: A Narrative Review of Microbiome Dysbiosis, Gut Barrier Dysfunction, and Metabolic Inflammation. | Cardiovasc Toxicol | 2026 | https://conductscience.org/library/papers/42862482 | PubMed |
| 42859560 | Gut microbiota dysbiosis: Pathogenic drivers and emerging phage-based therapeutics. | AIMS Microbiol | 2026 | https://conductscience.org/library/papers/42859560 | PubMed |
| 42764900 | Advances of oral micro- and nanomedicines for modulating intestinal barriers in the treatment of intestinal diseases. | Acta Pharm Sin B | 2026 | https://conductscience.org/library/papers/42764900 | PubMed |
| 42737658 | Effects of a Chemically Characterised Multi-Component Nutraceutical Formulation on Intestinal, Hepatic and Skeletal Muscle Responses in an In Vitro Gut-Liver-Muscle Model. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42737658 | PubMed |
| 42723815 | Association of glucagon-like peptide-1 receptor agonists with atrial fibrillation recurrence after catheter ablation: a systematic review and meta-analysis. | Front Cardiovasc Med | 2026 | https://conductscience.org/library/papers/42723815 | PubMed |
| 42640624 | Gut microbial diversity at baseline conditions the clinical, microbiome, and metabolic response to paraprobiotic Lactiplantibacillus plantarum LRCC5282 in overweight adults. | Gut Microbes | 2026 | https://conductscience.org/library/papers/42640624 | PubMed |
| 42482485 | Intestinal Organoids as Models to Study Viruses: Current Application and Future Perspective. | J Microbiol Biotechnol | 2026 | https://conductscience.org/library/papers/42482485 | PubMed |
| 42444516 | Intestinal gases as markers to study the diet-gut microbiota-host metabolism axis in humans and their relationship to metabolic health. | Gut Microbes | 2026 | https://conductscience.org/library/papers/42444516 | PubMed |
| 42295694 | Hypocholesterolemic agents and the gut microbiota: a review of interactions and modulatory activity. | Pharmacol Rep | 2026 | https://conductscience.org/library/papers/42295694 | PubMed |
| 42280144 | Natural Bioactive Compounds Targeting Gut Barrier Integrity and Metabolic Endotoxemia in Cardiometabolic Disease: Mechanistic Insights and Translational Perspectives. | Molecules | 2026 | https://conductscience.org/library/papers/42280144 | PubMed |
| 42131237 | Gut microbiota-liver-kidney axis in diabetic kidney disease: mechanistic insights into amino acid metabolism and nutritional intervention strategies targeting natural bioactive compounds. | Front Nutr | 2026 | https://conductscience.org/library/papers/42131237 | PubMed |
| 42075146 | Effects of the Synbiotic Formulation EDC-HHA01 on Glucose Regulation in Adults with Type 2 Diabetes and Prediabetes: A Randomized, Placebo-Controlled Study. | Microorganisms | 2026 | https://conductscience.org/library/papers/42075146 | PubMed |
| 42051455 | Gut microbiome dysbiosis in PCOS: from pathogenesis to microbiome-targeted therapies. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42051455 | PubMed |
| 41939722 | Food-derived molecules as regulators of intestinal tight junctions and barrier function: mechanisms and implications. | Front Drug Deliv | 2026 | https://conductscience.org/library/papers/41939722 | PubMed |
| 41915357 | Odevixibat ameliorates high-fat diet-induced MASLD in mice by targeting the gut microbiota-metabolite axis and enhancing gut-liver crosstalk. | J Physiol Biochem | 2026 | https://conductscience.org/library/papers/41915357 | PubMed |
| 41900814 | Natural Extract Combination Modulates Intestinal Barrier and Hepatic Cholesterol via the Gut-Liver Axis In Vitro. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/41900814 | PubMed |
| 41872245 | Semaglutide restores metabolic and structural homeostasis along the gut-heart-metabolic axis in a cafeteria diet-induced obesity model. | Sci Rep | 2026 | https://conductscience.org/library/papers/41872245 | PubMed |
| 41834567 | Limosilactobacillus reuteri ATG-F4 Ameliorates Dexamethasone-Induced Muscle Atrophy through Modulation of Gut Microbiota. | J Microbiol Biotechnol | 2026 | https://conductscience.org/library/papers/41834567 | PubMed |
Genes19
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36937361
GET https://conductscience.org/api/papers/v1/36937361/references?page=2